Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.34 |
| ▸ | FDPS | P14324 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 5/20 | 0.34 |
| ▸ | CA1 | P00915 | 2/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | FAAH | O00519 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21313332 | 0.93 | MAPT (0.43) | MAPTFDPSCA1FAAH | |
| SCHEMBL578777 | 0.84 | — | — | |
| SCHEMBL45380 | 0.79 | DNM1 (0.38) | ALDH1A1TDP1MAPTDNM1TSHR | |
| SCHEMBL831154 | 0.76 | MAPT (0.38) | MAPTDNM1TSHRFDPSSMN1; SMN2 | |
| SCHEMBL23825077 | 0.75 | FDPS (0.36) | ALDH1A1MAPTDNM1FDPSCA2 | |
| SCHEMBL22398662 | 0.75 | DNM1 (0.35) | ALDH1A1TDP1MAPTDNM1TSHR | |
| SCHEMBL833676 | 0.75 | DNM1 (0.35) | ALDH1A1TDP1MAPTDNM1TSHR | |
| SCHEMBL23825068 | 0.75 | FDPS (0.36) | ALDH1A1MAPTDNM1FDPSCA2 | |
| SCHEMBL45136 | 0.75 | DNM1 (0.35) | ALDH1A1TDP1MAPTDNM1TSHR | |
| SCHEMBL28292487 | 0.75 | DNM1 (0.35) | ALDH1A1TDP1MAPTDNM1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3992177-B1 | DERIVATIVE COMPOUND INTRODUCING BIPHENYL GROUP INTO NOVEL AMINOALKANOIC ACID AND ANTIFUNGAL PHARMACEUTICAL COMPOSITION COMPRISING SAME | AMTIXBIO CO LTD (KR) | 2024-05-08 | — | — | EP | disclosed |
| EP-4349329-A1 | BENZYLOXY-BENZYLAMINYL AMINO ACID DERIVATIVE FOR ADJUSTING TSLP/TSLPR SIGNAL TRANSMISSION | Amtixbio Co., Ltd. (KR) | 2024-04-10 | — | — | EP | disclosed |
| US-20230067422-A1 | AMINOALKANOIC ACID DERIVATIVE CONTAINING BIPHENYL GROUP AND USE OF THE SAME | AMTIXBIO CO., LTD. (KR) | 2023-03-02 | — | — | US | disclosed |
| US-20230056812-A1 | METHOD FOR PREPARING AMINOALKANOIC ACID DERIVATIVE CONTAINING BIPHENYL GROUP | AMTIXBIO CO., LTD. (KR) | 2023-02-23 | — | — | US | disclosed |
| US-20230053855-A1 | PHARMACEUTICAL COMPOSITION COMPRISING AMINOALKANOIC ACID DERIVATIVE CONTAINING BIPHENYL GROUP | AMTIXBIO CO., LTD. (KR) | 2023-02-23 | — | — | US | disclosed |
| WO-2022255801-A1 | BENZYLOXY-BENZYLAMINYL AMINO ACID DERIVATIVE FOR ADJUSTING TSLP/TSLPR SIGNAL TRANSMISSION | (주)앰틱스바이오 | 2022-12-08 | — | — | WO | disclosed |
| US-20220144755-A1 | NOVEL AMINOALKANOIC ACID DERIVATIVE CONTAINING BIPHENYL GROUP AND ANTIFUNGAL PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | AMTIXBIO CO., LTD. (KR) | 2022-05-12 | — | — | US | disclosed |
| EP-3992177-A1 | DERIVATIVE COMPOUND INTRODUCING BIPHENYL GROUP INTO NOVEL AMINOALKANOIC ACID AND ANTIFUNGAL PHARMACEUTICAL COMPOSITION COMPRISING SAME | Amtixbio Co., Ltd. (KR) | 2022-05-04 | — | — | EP | disclosed |
| CN-114051496-A | Derivative compound for introducing biphenyl group into novel amino alkanoic acid and antifungal pharmaceutical composition comprising same | 阿米蒂比奥有限公司 | 2022-02-15 | — | — | CN | disclosed |
| US-20200199065-A1 | FUNCTIONAL DERIVATIVE COMPOUNDS OF ALANINE AND PROLINE AMINO ACIDS AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | AMTIXBIO CO., LTD. (KR) | 2020-06-25 | — | — | US | disclosed |
| US-20120220593-A1 | Substituted Acrylamide Derivative and Pharmaceutical Composition Comprising the Same | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2012-08-30 | — | — | US | disclosed |
| US-8143446-B2 | Substituted acrylamide derivative and pharmaceutical composition comprising the same | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2012-03-27 | — | — | US | disclosed |
| US-20120040936-A1 | CYCLIC COMPOUND HAVING SUBSTITUTED PHENYL GROUP | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2012-02-16 | — | — | US | disclosed |
| EP-2418203-A1 | CYCLIC COMPOUND HAVING SUBSTITUTED PHENYL GROUP | Daiichi Sankyo Company, Limited (JP) | 2012-02-15 | — | — | EP | disclosed |
| US-20110269746-A1 | CYCLIC COMPOUND HAVING HETERO ATOM | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2011-11-03 | — | — | US | disclosed |
| EP-2380878-A1 | CYCLIC COMPOUND HAVING HETERO ATOM | Daiichi Sankyo Company, Limited (JP) | 2011-10-26 | — | — | EP | disclosed |
| US-20090292024-A1 | SUBSTITUTED PROPANAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2009-11-26 | — | — | US | disclosed |
| US-20090118199-A1 | SUBSTITUTED ACRYLAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | DAIICHI SANKYO COMPANY , LIMITED (JP) | 2009-05-07 | — | — | US | disclosed |
| EP-1908466-A1 | SUBSTITUTED PROPANAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | Daiichi Sankyo Company, Limited (JP) | 2008-04-09 | — | — | EP | disclosed |
| EP-1880720-A1 | SUBSTITUTED ACRYLAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | Daiichi Sankyo Company, Limited (JP) | 2008-01-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120040936-A1 | CYCLIC COMPOUND HAVING SUBSTITUTED PHENYL GROUP | BMP2, BMP4, BMP6 | ALDH1A1 2092/4885TDP1 4614/4885MAPT 4571/4885 |
| US-20090292024-A1 | SUBSTITUTED PROPANAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | PTMS, C1S, ACP3 | ALDH1A1 298/4885TDP1 3856/4885MAPT 3124/4885 |
| US-20230053855-A1 | PHARMACEUTICAL COMPOSITION COMPRISING AMINOALKANOIC ACID DERIVATIVE CONTAINING BIPHENYL GROUP | AHR, AADAC, GABBR1 | ALDH1A1 1001/4885TDP1 3446/4885MAPT 1422/4885 |
| US-20110269746-A1 | CYCLIC COMPOUND HAVING HETERO ATOM | BMP2, BMP4, BMP1 | ALDH1A1 3358/4885TDP1 4811/4885MAPT 4445/4885 |
| US-20090118199-A1 | SUBSTITUTED ACRYLAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | ACR, NAT1, C1S | ALDH1A1 75/4885TDP1 1470/4885MAPT 2207/4885 |
| US-20220144755-A1 | NOVEL AMINOALKANOIC ACID DERIVATIVE CONTAINING BIPHENYL GROUP AND ANTIFUNGAL PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | AADAC, GABBR1, AHR | ALDH1A1 1163/4885TDP1 3777/4885MAPT 2190/4885 |
| US-20230067422-A1 | AMINOALKANOIC ACID DERIVATIVE CONTAINING BIPHENYL GROUP AND USE OF THE SAME | GABBR1, AADAC, GABBR2 | ALDH1A1 628/4885TDP1 3705/4885MAPT 2615/4885 |
| US-20230056812-A1 | METHOD FOR PREPARING AMINOALKANOIC ACID DERIVATIVE CONTAINING BIPHENYL GROUP | AKR7A2, CYP51A1, APEH | ALDH1A1 613/4885TDP1 3497/4885MAPT 2911/4885 |
| US-20200199065-A1 | FUNCTIONAL DERIVATIVE COMPOUNDS OF ALANINE AND PROLINE AMINO ACIDS AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | PEPD, BCAT1, ANPEP | ALDH1A1 1968/4885TDP1 2289/4885MAPT 1844/4885 |
| US-20120220593-A1 | Substituted Acrylamide Derivative and Pharmaceutical Composition Comprising the Same | ACR, NAT1, C1S | ALDH1A1 75/4885TDP1 1470/4885MAPT 2207/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.